Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Quick Summary

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Apr 13, 2022 5:50pm

119 Views

Post# 34601999

RE:RE:RE:RE:RE:Quick Summary

What is incredible is that you apparently cannot read very well. Stop distorting and try to actually add some value to this top flight message board. We are all happy here to debate whatever negative sceario you want to put forward as we do alot of that already. I am not sure what purpose distorting things serves though.

Momo25 wrote: Every argument JFM made about his disappointment and dissatisfaction in regard with the company attitude and its evident absence of communication is faced by a counter argument from Speceo who made his feet in Paul Lvesque shoes. Incredible ! isn't it ?

<< Previous

Bullboard Posts

Next >>

New Found Gold begins surface trenching at Queensway